GONĚC, Tomáš, D. PINDJAKOVA, L. VRABLOVA, Tomáš STRHÁRSKY, H. MICHNOVA, Tereza KAUEROVÁ, Peter KOLLÁR, M. ORAVEC, I. JENDRZEJEWSKA, A. CIZEK and J. JAMPILEK. Antistaphylococcal Activities and ADME-Related Properties of Chlorinated Arylcarbamoylnaphthalenylcarbamates. Pharmaceuticals. BASEL: MDPI, 2022, vol. 15, No 6, p. 1-19. ISSN 1424-8247. Available from: https://dx.doi.org/10.3390/ph15060715.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Antistaphylococcal Activities and ADME-Related Properties of Chlorinated Arylcarbamoylnaphthalenylcarbamates
Authors GONĚC, Tomáš (203 Czech Republic, guarantor, belonging to the institution), D. PINDJAKOVA, L. VRABLOVA, Tomáš STRHÁRSKY (703 Slovakia, belonging to the institution), H. MICHNOVA, Tereza KAUEROVÁ (203 Czech Republic, belonging to the institution), Peter KOLLÁR (203 Czech Republic, belonging to the institution), M. ORAVEC, I. JENDRZEJEWSKA, A. CIZEK and J. JAMPILEK.
Edition Pharmaceuticals, BASEL, MDPI, 2022, 1424-8247.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.600
RIV identification code RIV/00216224:14160/22:00126255
Organization unit Faculty of Pharmacy
Doi http://dx.doi.org/10.3390/ph15060715
UT WoS 000816677300001
Keywords in English hydroxynaphthalenes; carbamates; antistaphylococcal activity; cytotoxicity; lipophilicity; structure-activity relationships
Tags rivok, ÚChL, ÚFTo
Tags International impact, Reviewed
Changed by Changed by: JUDr. Sabina Krejčiříková, učo 383857. Changed: 14/7/2022 09:26.
Abstract
Pattern 1-hydroxy-N-(2,4,5-trichlorophenyl)-2-naphthamide and the thirteen original carbamates derived from it were prepared and characterized. All the compounds were tested against Staphylococcus aureus ATCC 29213 as a reference and quality control strain and in addition against three clinical isolates of methicillin-resistant S. aureus (MRSA). Moreover, the compounds were evaluated against Enterococcus faecalis ATCC 29212, and preliminary in vitro cytotoxicity of the compounds was assessed using the human monocytic leukemia cell line (THP-1). The lipophilicity of the prepared compounds was experimentally determined and correlated with biological activity. While pattern anilide had no antibacterial activity, the prepared carbamates demonstrated high antistaphylococcal activity comparable to the used standards (ampicillin and ciprofloxacin), which unfortunately were ineffective against E. feacalis. 2-[(2,4,5-Trichlorophenyl)carba- moyl]naphthalen-1-yl ethylcarbamate (2) and 2-[(2,4,5-trichlorophenyl)carbamoyl]naphthalen-1-yl butylcarbamate (4) expressed the nanomolar minimum inhibitory concentrations (MICs 0.018-0.064 mu M) against S. aureus and at least two other MRSA isolates. Microbicidal effects based on the minimum bactericidal concentrations (MBCs) against all the tested staphylococci were found for nine carbamates, while 2-[(2,4,5-trichlorophenyl)carbamoyl]naphthalen-1-yl heptylcarbamate (7) and 2-[(2,4,5-trichlorophenyl)carbamoyl]naphthalen-1-yl (4-phenylbutyl)carbamate (14) demonstrated MBCs in the range of 0.124-0.461 mu M. The selectivity index (SI) for most investigated carbamates was >20 and for some derivatives even >100. The performed tests did not show an effect on the damage to the bacterial membrane, while the compounds were able to inhibit the respiratory chain of S. aureus.
PrintDisplayed: 21/7/2024 09:22